FDA approves Merck's new hepatitis C pill
U.S. regulators approved a new once-daily pill for the liver-destroying hepatitis C virus made by Merck & Co. Inc., which said it will sell the drug at a lower list price than its competitors. The list price for Zepatier will be $54,600 for a 12-week regimen, which Merck said it expects "to be in the range of net prices" for comparable treatments.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063